The sale resulted in aggregate gross proceeds of c. CHF 2.1 billion, of which EQT received c. CHF 555 million

STOCKHOLM, July 31, 2025 /PRNewswire/ -- Further to previous announcements, an affiliate of the funds known as EQT VIII ("EQT") is pleased to announce the completion of the placement of 17 million shares in Galderma Group AG (SIX: GALD) (the "Company") (the "Shares") for aggregate gross proceeds of c. CHF 2.1 billion via an accelerated bookbuilding process (the "Placement").

As part of the Placement, EQT received gross proceeds of c. CHF 555 million. The Placement was completed on 31 July 2025. BNP Paribas, Citigroup Global Markets, Goldman Sachs, Jefferies, Morgan Stanley and UBS acted as joint global coordinators and joint bookrunners for the Placement.

Contact
EQT Press Office, press@eqtpartners.com

Important notice

This press release does not constitute (i) an offer to sell or a solicitation of an offer to buy any securities of Galderma Group AG or any of its affiliates and it does not constitute a prospectus within the meaning of the Swiss Financial Services Act or (ii) an offer of securities for sale in the United States or elsewhere. Securities may not be offered or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration. There will be no public offering of any of the securities mentioned in this press release in the United States.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/eqt-completes-sale-of-shares-in-galderma-group-ag,c4213282

The following files are available for download:


     
     https://mb.cision.com/Main/87/4213282/3596407.pdf PR_EQT Galderma_31.07.25

View original content:https://www.prnewswire.co.uk/news-releases/eqt-completes-sale-of-shares-in-galderma-group-ag-302518931.html

Tags

More Like This

EQT completes sale of shares in Galderma Group AG

EQT completes sale of shares in Galderma Group AG

EQT completes sale of shares in Azelis Group NV

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba

Galderma Announces Full Exercise of Over-Allotment Option

Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering

Galderma Announces Intention to Float on the SIX Swiss Exchange

Galderma Successfully Placed an Inaugural EUR 500 Million Single Tranche Eurobond and New Dual Tranche CHF 435 Million CHF Bonds